An analysis by the Centers for Disease Control and Prevention (CDC) indicates a reduction in RSV hospitalization rates among infants and young children during the recent RSV season.
Health experts attribute this decline to the introduction of new vaccines and antibody therapies that enhance protection for the youngest and most vulnerable.
Kelsey Grimes, pediatrician at OSF HealthCare, stated, “But we have seen a drastic decrease in hospitalizations and ICU stays, which is usually when kids get the increased work of breathing and need oxygen and support.”
RSV remains one of the leading causes of hospitalizations for infants and young children in the U.S. It can cause severe respiratory illness, particularly in babies and children with underlying health conditions.
“These preventative options don’t stop RSV completely,” explained Grimes.
The CDC reports a 28% to 43% drop in RSV hospitalizations among infants compared to pre-pandemic RSV seasons.
Author’s summary: New vaccines and antibody treatments have significantly lowered RSV hospitalizations among infants, improving protection during the respiratory virus season.